10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The combination of diagnostics and imaging in infectious diseases offers a comprehensive approach to understanding and managing infections. Diagnostics, including microbiological tests and molecular assays, allow for the precise identification of causative agents, facilitating targeted treatments. Meanwhile, imaging techniques provide critical insight into the severity and extent of infection-related damage to organs or tissues. In infectious diseases diagnostics and imaging, advances such as positron emission tomography (PET) and magnetic resonance imaging (MRI) are increasingly being used to assess inflammation and infection in real-time, enabling personalized treatment plans. This integrated approach enhances both the detection of infections and the monitoring of treatment progress, ultimately leading to better clinical outcomes.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Artificial intelligence in the auxiliary diagnosis of hepatocellular carcinoma
Chen Ke, Army Medical University, China
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : A rare case report: Hepatitis due to Chlamydia trachomatis infection in a 50 year old male patient
Eszter Tothne Karip, Maitland Hospital, Australia
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States